Phase 2 trial: the study that started it all The Phase 2 trial, published in the New England Journal of Medicine under the title "Triple Hormone Receptor Agonist Retatrutide for Obesity," is the foundation upon which the entire Phase 3 program was built
Semaglutide standard 2 mg/mL concentration Tirzepatide standard 5 mg/mL concentration Retatrutide standard 5 mg/mL concentration Standard reconstitution steps all three compounds Gather a sterile U-100 insulin syringe, bacteriostatic water, alcohol swab, and peptide vial
Choosing the right format requires looking beyond the basic method of administration
When to Contact Your Doctor Temperature consistently above 38.5C on injection days Palpitations or chest discomfort accompanying flushing Symptoms worsening rather than stabilizing over the first 48 weeks Any doubt about whether what you're experiencing is the expected thermogenic effect or something else How Temperature Changes Evolve Over Time Based on the known pharmacology of glucagon and the dose titration schedule used in TRIUMPH trials: Weeks 14 (low dose, 2mg): Minimal thermogenic effect
Her ex-coach, Patrick Mouratoglou, has since admitted they had fights about her condition, adding that tennis is a sport in which you cant afford to be overweight
Our members also benefit from this technology via chatbots, virtual assistants, and the My Highmark app and digital experience
